Home › NDC Lookup › Ingredients › Docusate Sodium › 00904-6750-60
DOK docusate sodium 100 mg Tablet, 100-count — NDC 00904-6750-60 package photo

DOK docusate sodium 100 mg Tablet, 100-count

by MAJOR PHARMACEUTICALS · 100 TABLET in 1 BOTTLE (0904-6750-60)
NDC 00904-6750-60
🏷️ FDA NDC (as labeled) 0904-6750-60 billing pads the labeler segment with a zero
OTC On market Non-controlled
🗂️ Data synced Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

🆔 Identity & classification

FDA NDC (as labeled) 0904-6750-60
Product NDC 0904-6750
11-digit billing NDC 00904675060
NCPDP billing unit EA — each (per item)
RxCUI 1099279, 1483574
UNII F05Q2T2JA0
UPC 0309046750604
Application # M007
SPL Set ID 7a92070d-98cc-662f-e053-2991aa0aa1b2
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2018-06-01
Route ORAL
Dosage form TABLET
Substance DOCUSATE SODIUM
GPI-14 46500010300305
GPI class DOK
GCN Seq No 003020
GCN 09171
HICL code 001326
Ingredient (HICL) Docusate Sodium
HIC1 code D
Therapeutic class — broad (HIC1) Biliary System/Gastro-Intestinal System
HIC2 code D6
Therapeutic class — intermediate (HIC2) Drugs Acting Principally On The Colon
HIC3 code D6S
Therapeutic class — specific (HIC3) Laxatives And Cathartics
AHFS code 56:12.00.00
AHFS class Cathartics And Laxatives
FDB label name DOK 100 MG TABLET
FDB brand name Dok
Legend status O — Over-the-counter (OTC) drug or device
Why two NDCs? The FDA registers this code as 0904-6750-60 — a 4-4-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the labeler segment → 00904-6750-60. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏷️ RxNorm drug class

This medicine belongs to the Softeners, emollients class.

Drug family (ATC) Softeners, emollients
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

🏭 Manufacturer & labeler

LabelerMAJOR PHARMACEUTICALS
FDA applicationM007 (OTC MONOGRAPH DRUG)
Labeler code00904
First marketedJun 2018
Product typeHuman Otc Drug
Portfolio630 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

Label name DOK 100 MG TABLET Ingredient Docusate Sodium
🧪 What is this product?

DOK is an over-the-counter tablet containing docusate sodium, a stool softener. This product is an OTC monograph drug, meaning it is marketed under established FDA guidelines for its category rather than as an individually approved new drug. Docusate sodium is typically used to make bowel movements softer and easier by helping water mix into stool. People commonly use products with this ingredient when they want to relieve occasional constipation or when straining during bowel movements should be avoided.

Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII L11K75P92J
    A mineral salt made from calcium and phosphate. It acts as a filler and binder in tablets to add bulk and help hold the medicine together in solid form.
  • UNII M28OL1HH48
    Croscarmellose sodium is a plant-based substance derived from cellulose. It acts as a disintegrant, helping tablets and capsules break down quickly in the digestive system so the medicine can be absorbed.
  • UNII 70097M6I30
    Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
  • UNII OP1R32D61U
    Microcrystalline cellulose is a purified form of cellulose, a natural fiber from plant sources. It acts as a binder and filler in tablets and capsules, helping hold ingredients together and give the medicine its shape and size.
  • UNII ETJ7Z6XBU4
    Silicon dioxide is a naturally occurring mineral used as a glidant and anti-caking agent. It helps powder ingredients flow smoothly and prevents clumping during manufacturing and storage.
  • UNII OJ245FE5EU
    Sodium benzoate is a salt derived from benzoic acid, a preservative. It's added to medicines to prevent growth of bacteria, fungi, and other microorganisms that could spoil the product.
  • UNII 4ELV7Z65AP
    Stearic acid is a fatty acid derived from plant or animal sources. It acts as a binder and lubricant in tablets and capsules, helping them hold together and flow smoothly during manufacturing.
  • UNII 7SEV7J4R1U
    A powder made from a naturally occurring mineral. In medicines, talc works as a glidant and anti-caking agent, helping tablets and capsules flow smoothly during manufacturing and preventing clumping.

8 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statescellulose, croscarmellose sodium, dicalcium phosphate, magnesium stearate, silica, sodium benzoate, stearic acid, talc

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eaPer package
Retail pharmacies payNADAC · weekly $0.039 $3.90 / 100 tablets
Medicaid paysCMS SDUD · 12 mo $0.2073 $20.73 / 100 tablets
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per ea) — tap or hover for the price & month
Dec 2021 Sep 2022 Feb 2026 Sep 2026 $0.039 $0.026
▲ Up 40% over the last 22 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Dok 100 mgthis 00904-6750-60 MAJOR 100 tablets $0.039 — Availability likely —
Stool Softener 100 mg 70677-1071-01 STRATEGIC 100 tablets $0.039 — Availability likely —
Stool Softener 100 mg 57896-0421-01 Geri-Care 100 tablets — — FDA listed —
Stool Softener 100 mg 70677-1318-01 STRATEGIC 100 tablets — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

⏳ Availability & generic status

🏛️
2018
On the market since
Jun 2018
📍
2026
Currently FDA-listed
8 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

🗺️ Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for 00904-6750-60, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q1 2026 · 5 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
70.6K
Units reimbursed last 4 qtrs
2.9M
Gross reimbursed last 4 qtrs
$596.7K
Avg / prescription
$8.46
Avg / unit
$0.2073
Latest quarter Q1 2026
16.5KRx
Medicaid pays / ea
$0.2073
gross reimbursed
vs
NADAC / ea
$0.0390
acquisition cost
=
Spread
+$0.1683
+432% vs cost
What Medicaid paid per ea (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
61% FFS 39% MCO
Fee-for-service · 42,938 Rx Managed care · 27,632 Rx
State Medicaid map
Alaska: no data reported AK Maine: no data reported ME Washington: 416,836 units · 5,336 per 100k residents WA Idaho: no data reported ID Montana: 4,714 units · 416 per 100k residents MT North Dakota: no data reported ND Minnesota: 16,542 units · 288 per 100k residents MN Wisconsin: no data reported WI Michigan: 19,424 units · 194 per 100k residents MI New York: 270,253 units · 1,381 per 100k residents NY Vermont: no data reported VT New Hampshire: 6,173 units · 440 per 100k residents NH Oregon: 101,492 units · 2,398 per 100k residents OR Nevada: 9,787 units · 306 per 100k residents NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: no data reported IA Illinois: 93,601 units · 746 per 100k residents IL Indiana: 649,368 units · 9,463 per 100k residents IN Ohio: 261,710 units · 2,221 per 100k residents OH Pennsylvania: 272,405 units · 2,102 per 100k residents PA New Jersey: 26,452 units · 285 per 100k residents NJ Massachusetts: 92,305 units · 1,318 per 100k residents MA California: 64,071 units · 164 per 100k residents CA Utah: no data reported UT Colorado: 6,871 units · 117 per 100k residents CO Nebraska: 51,508 units · 2,604 per 100k residents NE Missouri: no data reported MO Kentucky: 284,556 units · 6,287 per 100k residents KY West Virginia: no data reported WV Virginia: 22,150 units · 254 per 100k residents VA Maryland: 25,403 units · 411 per 100k residents MD Connecticut: 22,112 units · 611 per 100k residents CT Rhode Island: no data reported RI Arizona: 24,932 units · 336 per 100k residents AZ New Mexico: 4,694 units · 222 per 100k residents NM Kansas: 89,685 units · 3,051 per 100k residents KS Arkansas: no data reported AR Tennessee: 1,251 units · 17.6 per 100k residents TN North Carolina: no data reported NC South Carolina: 8,584 units · 160 per 100k residents SC Delaware: 31,094 units · 3,016 per 100k residents DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: no data reported MS Alabama: no data reported AL Georgia: 510 units · 4.6 per 100k residents GA D.C.: no data reported DC Hawaii: no data reported HI Texas: no data reported TX Florida: no data reported FL
Units reimbursed · per 100k residents
4.69,463
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 Indiana 9,463 /100k
2 Kentucky 6,287 /100k
3 Washington 5,336 /100k
4 Kansas 3,051 /100k
5 Delaware 3,016 /100k
6 Nebraska 2,604 /100k
7 Oregon 2,398 /100k
8 Ohio 2,221 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

📦 Packaging — all sizes for this product

Package NDCDescription Marketing startStatus
00904-6750-60 You're viewing this 100 TABLET in 1 BOTTLE (0904-6750-60) 2018-06-01 Active

📄 FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose
🎯 Indications and Usage 14 words ▾

Uses relieves occasional constipation (irregularity) generally produces bowel movement in 12 to 72 hours

⏱️ Dosage and Administration 41 words ▾

Directions do not exceed recommended dose adults and children 12 years and older: take 1-3 tablets daily, or as directed by a doctor. May be taken as a single daily dose or in divided doses. children under 12: consult a doctor

⚠️ Warnings 80 words ▾

Warnings Ask a doctor before use if you have stomach pain, nausea or vomiting have a sudden change in bowel habits that persists over a period of 2 weeks are presently taking mineral oil Stop use and ask a doctor if you need to use a laxative longer than 1 week you have rectal bleeding or fail to have a bowel movement. These could be signs of a serious condition. If pregnant or breast-feeding, ask a health professional before use.

📦 Storage and Handling 31 words ▾

Other information each tablet contains: calcium 50 mg, sodium 10 mg store at room temperature 15°C-30°C (59°F-86°F) Tamper Evident: Do not use if imprinted seal under cap is missing or broken

🧪 Active Ingredient 6 words ▾

Active ingredient Docusate Sodium 100 mg

🧪 Inactive Ingredients 15 words ▾

Inactive ingredients cellulose, croscarmellose sodium, dicalcium phosphate, magnesium stearate, silica, sodium benzoate, stearic acid, talc

🎯 Purpose 4 words ▾

Purpose Stool Softener Laxative

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
← 00904-6748-17 · Major 00904-6751-80 · Major →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.